INMiND Office
European Institute for Molecular Imaging (EIMI) Waldeyerstr. 15 48149 Münster
Tel: +49 251 83 49300
Fax: +49 251 83 49313



Imaging of Neuroinflammation in Neurodegenerative Diseases

The goal of INMiND is to identify novel biological targets of neuroinflammation for both diagnostic and therapeutic purposes and to translate this knowledge into clinical application and patient benefit. This aim will be achieved through carrying out collaborative research on molecular mechanisms that link neuroinflammation with neurodegeneration.

Latest Publications

Non-invasive PET imaging of brain inflammation at disease onset predicts spontaneous recurrent seizures and reflects comorbidities.

[22.12.2016] Bertoglio D, Verhaeghe J, Santermans E, Amhaoul H, Jonckers E, Wyffels L, Van Der Linden A, Hens N, Staelens S, Dedeurwaerdere S. Brain Behav Immun. 2016 Dec 23. pii: S0889-1591(16)30563-3; epub ahead of print. more …

Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks.

[08.12.2016] Willekens SM, Van Weehaeghe D, Van Damme P, Van Laere K. Eur J Nucl Med Mol Imaging. 2016 Dec 8; epub ahead of print.
more …

Radiolabeled Selective Matrix Metalloproteinase 13 (MMP-13) Inhibitors: (Radio)Syntheses and in Vitro and First in Vivo Evaluation.

[29.11.2016] Hugenberg V, Wagner S, Kopka K, Schäfers M, Schuit RC, Windhorst AD, Hermann S. J Med Chem. 2016 Nov 29; epub ahead of print. more …

More Latest Publications

Latest News

Inmind Am2016 90

INMiND consortium met for the fourth time to discuss key achievements

[2016-02-26] For the fourth time the INMiND consortium came together to discuss the key developments the project achieved in questing the dynamics of microglia activation and its contribution to neuronal degeneration and regeneration by molecular imaging technologies in vivo under various paradigms including immunomodulation. more …

Aigner-ludwig-p03 90x90

Rejuvenation of the aged brain and recovery of cognitive functions by an already marketed anti-astmatic drug.

[2015-10-21] New research published in the Journal Nature Communications shows that Montelukast, an already marketed anti-asthmatic drug, reverts brain aging and loss of cognitive functions in old rodents that have received this drug for 6 weeks at dosages fully compatible with those currently used in patients. more …

Logo Consortia Pedia 90x90

Just released! INMiND profile included in the FasterCures' Consortia-pedia Catalogue.

[2015-10-21] INMiND is excited to be part of the recently launched Consortia-pedia Catalogue, a free, online catalogue of medical research consortia. Give it a try and check out INMiND's Consortia-pedia profile. more …

More News


INMiND Office
INMiND at a glance!
This collaborative project is funded by the Seventh Framework Programme of the European Union

Legal Disclosure | © 2017
INMiND Office
European Institute for Molecular Imaging (EIMI) Waldeyerstr. 15
· 48149 Münster
Tel: +49 251 83 49300 · Fax: +49 251 83 49313